Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sonoma Pharmaceuticals Inc (SNOA)

Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sonoma Pharmaceuticals Inc 5445 CONESTOGA COURT SUITE 150 BOULDER CO 80301 USA

www.sonomapharma.com P: 800-759-9305

Description:

Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.

Key Statistics

Overview:

Market Capitalization, $K 2,435
Enterprise Value, $K -955
Shares Outstanding, K 15,607
Annual Sales, $ 13,270 K
Annual Net Income, $ -5,150 K
Last Quarter Sales, $ 3,140 K
Last Quarter Net Income, $ -870 K
EBIT, $ -4,440 K
EBITDA, $ -4,310 K
60-Month Beta 1.27
% of Insider Shareholders 9.20%
% of Institutional Shareholders 1.95%
Float, K 14,171
% Float 90.80%
Short Volume Ratio 0.48

Growth:

1-Year Return -83.73%
3-Year Return -97.90%
5-Year Return -98.00%
5-Year Revenue Growth -20.35%
5-Year Earnings Growth 96.17%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 02/08/24
Latest Earnings Date 06/19/24
Earnings Per Share ttm -0.78
EPS Growth vs. Prev Qtr 70.00%
EPS Growth vs. Prev Year 88.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-9 on 06/20/19

SNOA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -58.93%
Return-on-Assets % -26.92%
Profit Margin % -38.81%
Debt/Equity 0.01
Price/Sales 0.08
Price/Cash Flow N/A
Price/Book 0.31
Book Value/Share 0.49
Interest Coverage -0.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar